The Wilcoxon–Mann–Whitney Estimand Versus Differences in Medians or Means

There is a renewed interest in defining the target of estimation when designing randomized trials. Motivated by design work in trials of HIV-1 curative interventions, we compare the Wilcoxon-Mann-Whitney (WMW) estimand to a difference in medians or means in a two-arm study. First, we define each estimand along with an appropriate estimator. Then, we highlight relevant asymptotic relative efficiency (ARE) results for the estimators under normal distributions (ARE: WMW/mean = <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"> <mml:semantics><mml:mrow><mml:mn>3</mml:mn> <mml:mo>/</mml:mo> <mml:mi>π</mml:mi></mml:mrow> <mml:annotation>$$ 3/\pi $$</mml:annotation></mml:semantics> </mml:math> , median/mean = <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"> <mml:semantics><mml:mrow><mml:mn>2</mml:mn> <mml:mo>/</mml:mo> <mml:mi>π</mml:mi></mml:mrow> <mml:annotation>$$ 2/\pi $$</mml:annotation></mml:semantics> </mml:math> , median/WMW = <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"> <mml:semantics><mml:mrow><mml:mn>2</mml:mn> <mml:mo>/</mml:mo> <mml:mn>3</mml:mn></mml:mrow> <mml:annotation>$$ 2/3 $$</mml:annotation></mml:semantics> </mml:math> ), as well as normal mixtures. Measurement of outcomes related to HIV-1 cure involve laboratory assays with lower limits of quantification giving rise to left-censored data. In our simulation study, we compare the estimators in the presence of left-censored observations and at small sample sizes, illustrating that under a censored normal mixture distribution the WMW approach is unbiased, powerful, and has confidence intervals with nominal coverage. We apply our findings to a randomized trial designed to reduce HIV-1 reservoirs. We further expose several extensions of the WMW approach that allows for assessment of interactions between subgroups in a trial, adjustment for covariates, and general ranking methods for clinical outcomes in other disease areas. We end with a discussion summarizing the merits of a WMW based intervention effect estimate versus an estimate summarized on the scale the intervention was originally measured such as the difference in medians or means.

Authors

Institutions

Publication Details

Journal
Pharmaceutical Statistics
Published
2025-08-12
DOI
https://doi.org/10.1002/pst.70036
Primary Topic
Statistical Methods and Bayesian Inference
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Wilcoxon–Mann–Whitney Estimand Versus Differences in Medians or Means

Ronald J. Bosch, Linda J. Harrison
1 links
Pharmaceutical Statistics
Statistical Methods and Bayesian Inference
article

The Wilcoxon–Mann–Whitney Estimand Versus Differences in Medians or Means

Ronald J. Bosch, Linda J. Harrison
article en

Abstract

There is a renewed interest in defining the target of estimation when designing randomized trials. Motivated by design work in trials of HIV-1 curative interventions, we compare the Wilcoxon-Mann-Whitney (WMW) estimand to a difference in medians or means in a two-arm study. First, we define each estimand along with an appropriate estimator. Then, we highlight relevant asymptotic relative efficiency (ARE) results for the estimators under normal distributions (ARE: WMW/mean = <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"> <mml:semantics><mml:mrow><mml:mn>3</mml:mn> <mml:mo>/</mml:mo> <mml:mi>π</mml:mi></mml:mrow> <mml:annotation>$$ 3/\pi $$</mml:annotation></mml:semantics> </mml:math> , median/mean = <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"> <mml:semantics><mml:mrow><mml:mn>2</mml:mn> <mml:mo>/</mml:mo> <mml:mi>π</mml:mi></mml:mrow> <mml:annotation>$$ 2/\pi $$</mml:annotation></mml:semantics> </mml:math> , median/WMW = <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"> <mml:semantics><mml:mrow><mml:mn>2</mml:mn> <mml:mo>/</mml:mo> <mml:mn>3</mml:mn></mml:mrow> <mml:annotation>$$ 2/3 $$</mml:annotation></mml:semantics> </mml:math> ), as well as normal mixtures. Measurement of outcomes related to HIV-1 cure involve laboratory assays with lower limits of quantification giving rise to left-censored data. In our simulation study, we compare the estimators in the presence of left-censored observations and at small sample sizes, illustrating that under a censored normal mixture distribution the WMW approach is unbiased, powerful, and has confidence intervals with nominal coverage. We apply our findings to a randomized trial designed to reduce HIV-1 reservoirs. We further expose several extensions of the WMW approach that allows for assessment of interactions between subgroups in a trial, adjustment for covariates, and general ranking methods for clinical outcomes in other disease areas. We end with a discussion summarizing the merits of a WMW based intervention effect estimate versus an estimate summarized on the scale the intervention was originally measured such as the difference in medians or means.

Pharmaceutical StatisticsVol. 24(5)
Cancer Research And Biostatistics (US)
ACT Government, National Institutes of Health, National Institute of Allergy and Infectious Diseases
Good health and well-being
Openalex Percentile: Top 80%
Statistical Methods and Bayesian Inference
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.